Pure Global
NCT03010852

Focused Incentive Spirometry Monitoring to Reduce Postoperative Oxygen Therapy and Respiratory Complications After Bariatric Surgery

University of Colorado, Denver·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Respiratory Complication
Drug/Device/Intervention
Focused incentive spirometer education and monitoring
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Colorado, Denver
Location
Aurora, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2016
End date
Dec 01, 2020
Enrollment
60 participants
Primary outcome

Frequency of at least one episode of moderate/severe hypoxemic event

Summary

Postoperative (PO) hypoventilation, atelectasis and hypoxemia after bariatric surgery are
 common and multifactorial, contributing to prolonged oxygen (O2) therapy after surgery and
 even at hospital discharge. Incentive spirometry (IS) is recommended postoperatively but its
 success in preventing postoperative atelectasis and hypoxemia (POH) heavily depends on
 patient compliance with IS effort and frequency. The investigators hypothesize that a focused
 education preoperatively on IS for POH and intensive monitoring of patient compliance with IS
 therapy in the early postoperative period shortens postoperative oxygen therapy, decreases
 POH episodes, and improves respiratory outcomes after bariatric surgery, compared to patients
 receiving standard of care.

ICD-10 classifications
Respiratory disorder, unspecifiedOther respiratory disordersRespiratory failure, unspecifiedOther postprocedural respiratory disordersOther specified respiratory disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03010852
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03010852 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Colorado, Denver and is currently Completed. The study focuses on Respiratory Complication. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.